San Francisco Suspect Arrested After Molotov Cocktail Attack on OpenAI CEO Sam Altman's Home 
China's AI Stocks Surge as Zhipu and MiniMax Hit Record Highs 
BHP's Incoming CEO Visits China Amid Pricing Dispute with CMRG 
Lumentum Holdings Rides AI Wave With Order Book Filled Through 2028 
Rio Tinto's California Boron Assets Attract Over a Dozen Bidders, Valued at Up to $2 Billion 
Bank of America Identifies Top Asia-Pacific Semiconductor Stocks Poised for AI-Driven Growth 
Foreign Investors Pour $18.65 Billion into Japanese Stocks Amid Market Stabilization 
SanDisk Joins Nasdaq-100, Replacing Atlassian on April 20 
Alibaba Shares Slide as Jefferies Slashes Price Target Over AI Spending and Business Losses 
Kia Cuts EV Sales Target for 2030 Amid Slowing Demand and U.S. Policy Shifts 
China Vanke Seeks Bond Extension Amid Mounting Debt Crisis 
Goldman Sachs, ANZ Cut Oil Forecasts Amid U.S.-Iran Ceasefire Hopes 
Disney Plans to Cut 1,000 Jobs Amid Ongoing Restructuring Efforts 
Chinese Brands Are Taking Over Brazil — And It's Just Getting Started 
TSMC Posts Strong Q1 2025 Revenue, Riding AI Chip Demand Wave 
Chinese Cars in Europe: Consumer Trust Is Shifting Fast 
Bill Ackman Eyes New Fund to Bet Against Market Complacency 
Albuquerque, NM, Oct. 04, 2017 -- Ultra Health, New Mexico’s #1 Cannabis Company, achieved $1.1 million in sales for the month of September 2017, the highest single month revenue ever recorded by a New Mexico cannabis provider. It is the first time a licensed New Mexico producer has achieved greater than $1 million for a single month. There are currently 35 licensed commercial medical cannabis producers in New Mexico serving nearly 50,000 patients.
|
|||
Ultra Health recently opened its eighth location serving six New Mexico counties and became the nation’s largest vertically integrated solely medical cannabis provider.
“The milestone achieved is a direct reflection of how the New Mexico Medical Cannabis Program is sustaining its upward momentum,” said Duke Rodriguez, CEO and President of Ultra Health®. “We remain committed to providing every patient in every county equal access to safe, affordable and convenient medicine. The continued growth of the industry is fully dependent on new products, patients and locations being successfully integrated.”
Patients have responded favorably to Ultra Health’s new pharmaceutical-grade, smokeless medicinal products, which include sublingual and oral tablets, vaginal and rectal suppositories, oils, topicals, pastilles and patches.
“We are dedicated to enhancing patient choice, which means giving all patients the healthy advantages of purchasing accurately dosed medications with varied delivery methods, much like you would purchase from your neighborhood pharmacy,” Rodriguez said.
As of August 31, 2017, the New Mexico Department of Health reported 46,988 medical cannabis patients enrolled in the program. Currently, thousands of patients still reside in 14 counties without a full time dispensary. New Mexico is the 5th largest state by area, which makes rural access challenging but essential for improved health.
New Mexico’s medical cannabis industry is expected to reach $90 million in revenue by the end of the current year and hit $205 million by 2020.
Attachments:
http://www.globenewswire.com/NewsRoom/AttachmentNg/90541969-a619-43e6-966f-7ea6a0cda926
Attachments:
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/af02116e-bf76-48f6-9c34-75ab3199ca6d
Marissa Novel Ultra Health 480-404-6699 [email protected]
